Chapter 445 - 265
Chapter 445: Chapter 265
The announcement was made on the government’s official website.
Wu Ting clicked on the "Decision" to read it.
The "Decision" stated its hope that the commended young and middle-aged experts would cherish the honor and continue to strive for new and greater achievements.
It also expressed the hope that all experts and technical professionals throughout the province would look to these advanced role models, dedicate themselves to their work, study diligently, innovate, and forge ahead to achieve success in this new era and on this new journey!
...
Reading the entire decision made Wu Ting’s blood boil with excitement. He scanned the full list of awardees and found he was the only recipient from Fan City.
He was also, to date, the twelfth expert from all of Fan City to ever receive this distinguished honor.
This was undoubtedly the highest form of recognition and an affirmation of Wu Ting’s current work and research accomplishments.
While Wu Ting was reading the decision, a link to the news of his award was posted in the City First Hospital’s employee group chat.
Everyone in the group was @’ing Wu Ting with congratulations and well wishes!
This was yet another prestigious award for Wu Ting.
That morning, City First Hospital hung a red banner at the entrance of the emergency building, congratulating Wu Ting on receiving the honorary title of "Jin Province Young and Middle-Aged Expert with Outstanding Contributions"!
City First Hospital’s website homepage, official social media account, and official short-video channel all pushed out the good news simultaneously.
With this official government support, Wu Ting was suddenly thrust into the spotlight, drawing attention from all sectors of society.
Fan City TV Station even conducted a special interview with Wu Ting.
During the interview, Wu Ting deliberately introduced the new research project from his Yangtze River Delta Hepatic Tumor Center, welcoming relevant patients to come to the Hepatic Tumor Surgery department at City First Hospital for treatment.
This official encouragement and support undoubtedly served as a major boost to the authority and influence of Wu Ting’s team.
It wasn’t just domestic professionals and patients in related fields who took notice; even the international community became aware of this method from Jin Country, dubbed the "Groundbreaking Three-Stage Systematic Diagnosis and Treatment Method for the Complete Radical Cure of HBV-Related Primary Liver Cancer."
At the University of Texas MD Anderson Cancer Center in the Southern Country, Professor Edwards also took note of this research project from Jin Country.
Across from him was Dr. Laura, the Secretary-General of the International Liver Cancer Association.
Laura was a bisexual woman who didn’t believe in marriage. Before becoming the Secretary-General of the International Liver Cancer Association, she had worked for pharmaceutical companies and magazine publishers, making her a highly influential and well-known leader in the medical field.
A Yale University graduate, Laura’s father was a prominent lawyer and her mother a business elite. Consequently, she boasted an outstanding educational and family background, and her personal abilities were equally impressive.
Laura was a typically proud and domineering white elite from the Southern Country. She held no goodwill toward the people of Jinzhou—these yellow-skinned doctors and scientists from Jin Country—and lacked even basic respect for them.
"Mr. President, it seems I’ll need to take a trip to Jin Country to meet this fledgling upstart."
As the ambitious president of the International Liver Cancer Association, Edwards was pushing his "Neutrino" project with all his might, intending to make his research the global industry standard and expert consensus for treating HBV-related primary liver cancer. Naturally, he would not allow a team like Wu Ting’s to exist.
Edwards reviewed the research and core papers from Wu Ting’s team. After reading them, he was both shocked and delighted.
"Laura, here’s the plan. On this trip to Jin Country, find this Dr. Wu Ting and have a good chat with him."
"We can offer him a position as a standing council member of the International Liver Cancer Association and, at the same time, invite him to join our soon-to-be-established international research group for HBV-related primary liver cancer."
"A young doctor from Jin Country like him will naturally be weeping with gratitude under such generous terms. Then, you can promise to authorize his hospital for the first batch of Neutrino devices."
"Once he joins the association and accepts the appointment, he will naturally be required to unconditionally share the research results he has with our association."
"I think you understand what comes next."
Edwards looked at Laura.
Laura, blonde-haired and blue-eyed, shrewd and beautiful, gave a relaxed nod.
"Of course, Mr. President. Just wait for my good news. For an unknown young man from an Eastern country to receive recognition and an invitation from our International Liver Cancer Association based on his little project... he simply wouldn’t have the guts to refuse."
As the Secretary-General of the International Liver Cancer Association, Laura had spoken to and met with far too many expert professors from the countries of Jinzhou. Which one of them wasn’t polite and deferential in her presence?
Joining the International Liver Cancer Association was an unparalleled honor for them. A title like this, in those Eastern countries, was far more prestigious and influential than any title from their own domestic hospitals.
To apply pressure on Wu Ting’s team, Laura also contacted her former employer, the International Journal of Hepatobiliary and Pancreatic Diseases.
That very day, the journal published a commentary from the International Liver Cancer Association on the project by Dr. Wu Ting’s team at Fan City First Hospital in Jin Country.
In the article, the International Liver Cancer Association’s assessment of Wu Ting’s team’s research was that it was "misguided," "deviating from the correct path," and "nonetheless, the flaws do not overshadow the virtues."
The International Liver Cancer Association leveraged its influence and its council members spread across the globe to present an authoritative opinion: that the Neutrino treatment technology was the true future for the diagnosis and treatment of HBV-related primary liver cancer.
As for the research by Wu Ting’s team, they claimed its path held no novelty. Immunotherapy and antiviral treatments had long been verified by numerous teams and clinical trials and had been proven ineffective as a primary approach.